Acuta Capital Partners, LLC Mannkind Corp Transaction History
Acuta Capital Partners, LLC
- $70.3 Million
- Q4 2024
A detailed history of Acuta Capital Partners, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 107,500 shares of MNKD stock, worth $582,650. This represents 0.04% of its overall portfolio holdings.
Number of Shares
107,500Holding current value
$582,650% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MNKD
# of Institutions
260Shares Held
161MCall Options Held
1.99MPut Options Held
1.09M-
Black Rock Inc. New York, NY22.6MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$87 Million0.0% of portfolio
-
State Street Corp Boston, MA9.95MShares$53.9 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$47.4 Million0.82% of portfolio
-
Nitorum Capital, L.P. New York, NY8.75MShares$47.4 Million8.23% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.39B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...